Movie Industry

Michael Jackson Movie 'Michael' Earns $1 Billion… First and Highest-Grossing Biopic Ever

Surpassing 'Oppenheimer' and 'Bohemian Rhapsody' Second $1 billion film of the year

Choi Hee-jae
2026-07-15 16:22:21
[E-Daily Starin Choi Hee-jae Reporter] The film “Michael,” which chronicles the life of the “King of Pop” Michael Jackson, has grossed over $1 billion (approximately 1.49 trillion won) at the box office. This marks the first time a biopic has achieved such a feat and sets a new record for the highest-grossing biopic of all time.
Poster for the movie “Michael.” (Photo: Universal Pictures)

According to the U.S. entertainment media outlet Variety on the 13th (local time), “Michael” has surpassed $1 billion in global box office revenue. Since its release, the film has earned $371.8 million in North America and $629.8 million in international markets, for a total of $1,001.6 million.
Among biopics, it has surpassed Christopher Nolan’s “Oppenheimer” (2023, $975 million), which chronicles the life of physicist Julius Robert Oppenheimer, and “Bohemian Rhapsody” (2018, $911 million), which tells the story of the legendary rock band Queen and Freddie Mercury.
Director Antoine Fuqua, who helmed “Michael,” said, “This achievement belongs to everyone who came together with the shared goal of honoring one of the greatest artists of all time,” adding, “I sincerely thank audiences around the world who connected with this story across generations and cultures.”
Universal Pictures’ animated film “Super Mario Galaxy” ($1.008 billion) was the first film this year to reach the $1 billion mark, with “Michael” being the second. Disney’s “Toy Story 5” is projected to become the third film this year to surpass $1 billion.
“Michael” is a film that brings Michael Jackson’s life and music to the screen; it has earned critical acclaim for its stage direction—which feels like a live concert—and its overwhelming sound.

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

SCL Science Takes on Liver and Ovarian Cancer Vaccines… Aims to File IND Application Next Year [Invest Bio]

SCL Science(246960)is accelerating its new drug development efforts, spearheaded by vaccines for liver and ovarian cancer. With the goal of submitting an Investigational New Drug (IND) application nex…
2026-10-24 06:01:03

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02